Login to Your Account



Search

Search results

Pharma: Clinic Roundup

• LEO Pharma UK , of Princes Risborough, UK, reported that data published in the Journal of the American Medical Association Dermatology demonstrated the long-term effectiveness of Picato (ingenol mebutate) in treating actinic keratosis (AK ...

BioWorld Today - Staff - 2013-03-22 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Teva Pharmaceuticals Industries Ltd. , of Jerusalem, said data that demonstrates significant differences in biological and immunological effects between Copaxone (glatiramer acetate, GA) and a purported generic glatiramer acetate (GA), marketed in In ...

BioWorld Today - Staff - 2014-01-14 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Cempra Inc. , of Chapel Hill, N.C., presented data at the American Thoracic Society International Conference (ATS 2013) in Philadelphia demonstrating the antibacterial and enhanced immunomodulatory activity of solithromycin vs. levofloxacin i ...

BioWorld Today - Staff - 2013-05-21 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim GmbH , of Ingelheim, Germany, reported results from the phase III STARTVerso 4 trial in patients co-infected with hepatitis C virus (HCV) and HIV, showing that HCV cure 12 weeks (SVR12) after the conclusion of treatment was ach ...

BioWorld Today - Staff - 2014-03-07 01:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Roche AG , of Basel, Switzerland, presented new data from the LUTE/VERSE phase IIb studies investigating lebrikizumab in patients with severe uncontrolled asthma. The data showed that asthma attacks were reduced by 60 percent in lebrikizumab-trea ...

BioWorld Today - Staff - 2014-03-06 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Janssen Pharmaceutica NV , of Beerse, Belgium, part of Johnson & Johnson, reported results from the PROSIPAL (Prevention of Relapse With Oral Antipsychotics Versus Injectable Paliperidone Palmitate) study at the European Congress of Psychiatry ...

BioWorld Today - Staff - 2014-03-05 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Takeda Pharmaceutical Co. Ltd. , of Osaka, Japan, reported top-line results from the GEMINI I Phase III study of vedolizumab in 895 patients with moderately to severely active ulcerative colitis who have failed at least one conventional thera ...

BioWorld Today - Staff - 2012-02-22 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• The ALS Therapy Development Institute (ALS TDI) said it plans to launch a Phase II trial of TDI 132 (fingolimod/Gilenya) in amyotrophic lateral sclerosis. Gilenya, a first-in-class sphingosine-1-phosphate (S1P) receptor modulator marketed by ...

BioWorld Today - Staff - 2012-02-15 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim Corp. , of Ridgefield, Conn., part of Boehringer Ingelheim GmbH, presented data from phase III studies of tiotropium delivered via the Respimat inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of ...

BioWorld Today - Staff - 2014-03-04 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Eli Lilly and Co. , of Indianapolis, reported data from a Phase III study showing that both Cialis (tadalafil) and tamsulosin significantly improved scores on the International Prostate Symptom Score, compared to placebo, in men with signs an ...

BioWorld Today - Staff - 2012-02-08 01:00 - 0 comments - 0 attachments